SC

Sivaiah Cheelapalli

Director Additional Director DIN 07586203
DIN 07586203 First appointment Aug 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2016
Shareholding value •••• Premium profile

About Sivaiah Cheelapalli

Data last updated:

Sivaiah Cheelapalli was an Additional Director at Nami Lifesciences Private Limited (2016–2021) and Director at Neolife Pharmaceuticals Private Limited (2019–2022). The companies operate in Pharma.

DIN 07586203
Primary Designation Additional Director
Industry Pharma
First Appointment 16 Aug 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nami Lifesciences Private Limited U24304TG2016PTC111480
Additional Director16 Aug 20162016₹14.27 Cr (FY 2025)Active
Director03 Jan 20192019₹1.07 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nami Lifesciences Private Limited
Neolife Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sivaiah Cheelapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivaiah Cheelapalli

Sivaiah Cheelapalli was first appointed on 16 Aug 2016 as Additional Director at Nami Lifesciences Private Limited. The most recent appointment on record is 03 Jan 2019 at Neolife Pharmaceuticals Private Limited.

Sivaiah Cheelapalli held 2 earlier board appointments: Nami Lifesciences Private Limited (Additional Director, 16 Aug 2016 to 15 Sep 2021); Neolife Pharmaceuticals Private Limited (Director, 03 Jan 2019 to 25 Jan 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available